ROMANO KATHRYN

CIK 00018013851 companyPITTSBURGH, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001801385

Recent Transactions

50 trades

Award
Krystal Biotech, Inc.$KRYS
Stock Option (Right to Buy)
2025-02-28+10,000→ 10,000 total
Tax Payment
Krystal Biotech, Inc.$KRYS
Common Stock
2025-02-28$179.25/sh−3,471→ 19,318 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Performance Stock Units
2025-02-28−5,000→ 0 total
Award
Krystal Biotech, Inc.$KRYS
Restricted Stock Units
2025-02-28+2,200→ 2,200 total
Tax Payment
Krystal Biotech, Inc.$KRYS
Common Stock
2025-02-28$179.25/sh−2,315→ 15,289 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2025-02-28+5,000→ 17,604 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Performance Stock Units
2025-02-28−7,500→ 7,500 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2025-02-28+7,500→ 22,789 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2025-02-27$175.22/sh−750→ 12,604 total
Tax Payment
Krystal Biotech, Inc.$KRYS
Common Stock
2025-02-26$176.39/sh−2,268→ 13,354 total
Award
Krystal Biotech, Inc.$KRYS
Performance Stock Units
2024-02-29+15,000→ 15,000 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+203→ 13,139 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$167.85/sh−300→ 12,936 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+300→ 13,236 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+100→ 13,036 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$164.81/sh−1,429→ 12,936 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Stock Option (Right to Buy)
2024-02-28−5,000→ 30,000 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+1,216→ 14,152 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+523→ 13,459 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+300→ 13,236 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+200→ 13,136 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$163.13/sh−523→ 12,936 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+744→ 13,680 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$164.60/sh−744→ 12,936 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+130→ 13,066 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$165.22/sh−130→ 12,936 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$162.73/sh−637→ 12,936 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+786→ 13,722 total
Tax Payment
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$163.08/sh−2,314→ 15,622 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Stock Option (Right to Buy)
2024-02-28−5,000→ 25,000 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$164.84/sh−1,600→ 12,936 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$166.04/sh−200→ 12,936 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+1,133→ 14,069 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+134→ 13,070 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+1,600→ 14,536 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$169.09/sh−1,133→ 12,936 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+700→ 13,636 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$171.66/sh−134→ 12,936 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Stock Option (Right to Buy)
2024-02-28−2,500→ 35,000 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$169.47/sh−203→ 12,936 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$171.45/sh−100→ 12,936 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+637→ 13,573 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$167.85/sh−300→ 12,936 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$169.75/sh−210→ 12,936 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+648→ 13,584 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$162.71/sh−648→ 12,936 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+900→ 13,836 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$163.68/sh−900→ 12,936 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$63.55/sh+1,429→ 14,365 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-02-28$163.49/sh−786→ 12,936 total

Companies

Krystal Biotech, Inc.
Chief Accounting Officer
$KRYS

Recent Filings

Address

C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701

PITTSBURGH, PA, 15203

View on SEC.gov